Ngā hua rapu - Timothy R. Blake

  • E whakaatu ana i te 1 - 5 hua o te 5
Whakamahine hua
  1. 1
    mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice

    mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice mā Ole Audun Werner Haabeth, Timothy R. Blake, Colin J. McKinlay, Robert M. Waymouth, Paul A. Wender, Ronald Levy

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Reversible RNA acylation for control of CRISPR–Cas9 gene editing

    Reversible RNA acylation for control of CRISPR–Cas9 gene editing mā Maryam Habibian, Colin J. McKinlay, Timothy R. Blake, Anna M. Kietrys, Robert M. Waymouth, Paul A. Wender, Eric T. Kool

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals

    Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals mā Colin J. McKinlay, Jessica R. Vargas, Timothy R. Blake, Jonathan Hardy, Masamitsu Kanada, Christopher H. Contag, Paul A. Wender, Robert M. Waymouth

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Local Delivery of<i>Ox40l</i>,<i>Cd80</i>, and<i>Cd86</i>mRNA Kindles Global Anticancer Immunity

    Local Delivery of<i>Ox40l</i>,<i>Cd80</i>, and<i>Cd86</i>mRNA Kindles Global Anticancer Immunity mā Ole Audun Werner Haabeth, Timothy R. Blake, Colin J. McKinlay, Anders Tveita, Adrienne Sallets, Robert M. Waymouth, Paul A. Wender, Ronald Levy

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory

    An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory mā Ole Audun Werner Haabeth, Julian J.K. Lohmeyer, Adrienne Sallets, Timothy R. Blake, Idit Sagiv-Barfi, Debra K. Czerwinski, Blaine G. McCarthy, Abigail E. Powell, Paul A. Wender, Robert M. Waymouth, Ronald Levy

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: